Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13077
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tung, L H | en |
dc.contributor.author | Jackman, G | en |
dc.contributor.author | Campbell, B | en |
dc.contributor.author | Louis, Simon N S | en |
dc.contributor.author | Iakovidis, D | en |
dc.contributor.author | Louis, William J | en |
dc.date.accessioned | 2015-05-16T02:51:25Z | |
dc.date.available | 2015-05-16T02:51:25Z | |
dc.date.issued | 1993-03-01 | en |
dc.identifier.citation | Journal of Cardiovascular Pharmacology; 21(3): 484-8 | en |
dc.identifier.govdoc | 7681512 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/13077 | en |
dc.description.abstract | Celiprolol given intravenously (i.v.) to pithed rats in the dose range of 0.1-10,000 micrograms/g produced a dose-dependent increase in heart rate (HR) which was greatest (123 beats/min) at 1,000-3,000 micrograms/kg. This partial agonist effect was blocked by the selective beta 1-adrenoceptor antagonist CGP 20712A. Celiprolol also produced a vasodepressor effect in this dose range which was abolished by the relatively selective beta 2-adrenoceptor antagonist ICI 118551 but not CGP 20712A. The magnitude of this intrinsic sympathomimetic activity (ISA) response was not significantly altered by reserpine pretreatment. Celiprolol also antagonised the effects of isoprenaline 0.05 microgram/kg on HR and blood pressure (BP). The beta 1 selectivity of celiprolol as an antagonist in pithed rats (beta 1/beta 2 = 340:1) was similar to that observed in studies with isolated guinea pig atria and trachea (beta 1/beta 2 = 63:1), both being considerably greater than that observed with atenolol. Celiprolol, however, like atenolol, potentiated the bronchoconstrictor responses to histamine (3 micrograms/kg). Metabolic studies of rats and human urine failed to show significant amounts of potentially vasoactive metabolites. These data are consistent with celiprolol acting as both a beta 1- and beta 2- adrenoceptor partial agonist. | en |
dc.language.iso | en | en |
dc.subject.other | Adrenergic beta-Antagonists.pharmacology | en |
dc.subject.other | Airway Resistance.drug effects | en |
dc.subject.other | Animals | en |
dc.subject.other | Blood Pressure.drug effects | en |
dc.subject.other | Celiprolol.metabolism.pharmacology | en |
dc.subject.other | Decerebrate State | en |
dc.subject.other | Guinea Pigs | en |
dc.subject.other | Heart Rate.drug effects | en |
dc.subject.other | Imidazoles.pharmacology | en |
dc.subject.other | In Vitro Techniques | en |
dc.subject.other | Propanolamines.pharmacology | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Sprague-Dawley | en |
dc.subject.other | Receptors, Adrenergic, beta.drug effects | en |
dc.title | Partial agonist activity of celiprolol. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Cardiovascular Pharmacology | en |
dc.identifier.affiliation | Department of Clinical Pharmacology and Therapeutics, Austin Hospital, Heidelberg, Australia | en |
dc.description.pages | 484-8 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/7681512 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Louis, William J | |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.